Labiotech.eu was founded three years ago and has grown rapidly, tripling its visitors, since the first fundraising 18 months ago. It now welcomes nearly 100k monthly visitors and counts five of the largest life sciences companies as customers. This makes it the largest biotech platform in Europe, propelled by a team of 14 biotech enthusiasts.

The whole team believes biotech is an industry that has an enormous impact on making the world a better place through the development of cutting-edge and life-saving technologies, and that biotech information is not as accessible as it should be. Labiotech.eu is a platform providing digital information on the biotech ecosystem and its players, with topics such as innovation, investments, partnerships, discoveries and more.

This new round of capital will support Labiotech.eu’s growth and offer the team more resources for the creation of content and the launch of new products for their readers and clients.

“We’re thankful to our existing and new investors for their belief in our mission and for helping us to change how people are informed about biotech, ” said Philip Hemme and Joachim Eeckhout, founders of Labiotech.eu.

“ The team at Labiotech.eu has impressed us in the last 18 months and we are very happy to continue to work with them to support their vision,” commented Alexander Koelpin, MD & Partner WestTech Ventures.

About Labiotech.eu:
Labiotech.eu is the leading digital media covering the European Biotech industry. Nearly 100k people use it monthly to keep a watch on the business and innovations of biotechnologies, whether on the website or on the mobile apps.

Press kit: https://drive.google.com/drive/folders/0B2i8mWAnWHqCRUVmVGVrVnBDRFE
Team: http://labiotech.eu/team/
Story: http://labiotech.eu/story/
First fundraising: http://tech.eu/brief/labiotech-seed-funding/
Why is one of the most successful biotech entrepreneur in Europe reading Labiotech.eu:
http://labiotech.eu/curevac-ingmar-hoerr-reading-labiotech-eu/